Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Psychemedics Corporation PMD
$4.95
-$0.13 (-2.56%)
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
28878022.00000000
-
week52high
6.94
-
week52low
4.85
-
Revenue
25240000
-
P/E TTM
-29
-
Beta
0.61453200
-
EPS
-0.19000000
-
Last Dividend
0.28000000
-
Next Earnings Date
08 мая 2023 г. в 10:59
Описание компании
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| SCHAFFER MICHAEL I | A | 37201 | 100 | 16 дек 2022 г. |
| Doucot Charles M | D | 37675 | 1350 | 11 ноя 2022 г. |
| KUBACKI RAYMOND C JR | D | 249962 | 2625 | 11 ноя 2022 г. |
| SCHAFFER MICHAEL I | D | 37101 | 525 | 11 ноя 2022 г. |
| NEVIN DARIUS G | A | 9000 | 9000 | 12 авг 2022 г. |
| Kamin Peter | A | 223031 | 9000 | 12 авг 2022 г. |
| Davis Robyn C | A | 25000 | 12000 | 20 мая 2022 г. |
| Doucot Charles M | A | 39025 | 11000 | 20 мая 2022 г. |
| Reynolds Andrew | A | 14000 | 12000 | 20 мая 2022 г. |
| TOMENSON WALTER S | A | 74399 | 12000 | 20 мая 2022 г. |
Новостная лента
Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play
Seeking Alpha
25 апр 2022 г. в 15:46
21% YoY revenue growth in Q4, gross margins surge 1,000 bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense.
Small And Microcap Newsletter: DHT Holdings Financials Give It Time Until The Next Tanker Bull Market
Seeking Alpha
07 дек 2021 г. в 12:07
In this week's newsletter, we look at a company in the middle of monetizing its major asset to see what is left after the deal closes. We also review a shipping company that has built a strong margin of safety.
Psychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including Dividend
Seeking Alpha
18 ноя 2021 г. в 15:00
29% YoY revenue growth in Q3, margins surge.
Psychemedics: Market Leader, 8% FCF Yield, Possible Takeover Target
Seeking Alpha
18 окт 2021 г. в 09:50
Market-leading drug testing company, 30 years history, drug abuse increasing in the US. 13x P/E, 8% FCF yield on “normal” 2023 estimates.